Literature DB >> 16434968

Erasure of methylation imprint at the promoter and CTCF-binding site upstream of H19 in human testicular germ cell tumors of adolescents indicate their fetal germ cell origin.

T Kawakami1, C Zhang, Y Okada, K Okamoto.   

Abstract

Genome-wide epigenetic modification plays a crucial role in regulating genome functions at critical stages of development. In particular, DNA methylation is known to be reprogrammed on a genome-wide level in germ cells and in preimplantation embryos, although it is relatively stable in somatic cells. In this reprogramming process, the genome becomes demethylated, and methylated de novo during later stages of development. Reprogramming of DNA methylation in male germ cells has not been fully investigated. Testicular germ cell tumors (TGCTs) possess a pluripotential nature and display protean histology from germ cells to embryonal and somatic cell differentiation. These properties make TGCT a unique model for studying germ cell development and gametogenesis in respect of DNA reprogramming. In order to obtain an insight into the epigenetic dynamics of TGCTs, we conducted a comprehensive analysis of differential methylated regions (DMRs) on H19 and IGF2 in TGCTs compared with testicular malignant lymphomas. In the present study, we show that methylation imprint at the promoter and CTCF-binding site upstream of H19 was completely erased in both seiminomatous and non-seminomatous TGCTs, whereas differential methylation was observed in testicular lymphomas. The erasure of methylation imprint was also observed in TGCTs with malignant transformation. We found biallelic unmethylation at the promoter and the CTCF-binding site upstream of H19 is required, but not sufficient for the biallelic expression of H19 in TGCTs. These data suggest that factors other than methylation contribute to transcriptional regulation of imprinted genes in TGCTs. The present data have shown that TGCTs carry distinctive epigenetic profiles at the core-imprinting domain of H19/IGF2 from other neoplasms of somatic cell origin. The data also suggest that both seminomatous and non-seminomatous TGCTs carry methylation profiles similar to fetal germ cells, but not adult germ cells, indicating the origin of TGCTs as fetal germ cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16434968     DOI: 10.1038/sj.onc.1209362

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  6 in total

1.  Testicular germ cell tumor susceptibility genes from the consomic 129.MOLF-Chr19 mouse strain.

Authors:  Rui Zhu; Yuan Ji; Lianchun Xiao; Angabin Matin
Journal:  Mamm Genome       Date:  2007-08-02       Impact factor: 2.957

Review 2.  Toward a more precise and informative nomenclature describing fetal and neonatal male germ cells in rodents.

Authors:  John R McCarrey
Journal:  Biol Reprod       Date:  2013-08-29       Impact factor: 4.285

3.  Analysis of the Paternally-Imprinted DLK1-MEG3 and IGF2-H19 Tandem Gene Loci in NT2 Embryonal Carcinoma Cells Identifies DLK1 as a Potential Therapeutic Target.

Authors:  Zachariah Payne Sellers; Gabriela Schneider; Magdalena Maj; Mariusz Z Ratajczak
Journal:  Stem Cell Rev Rep       Date:  2018-12       Impact factor: 5.739

4.  DNA methylation analysis reveals distinct methylation signatures in pediatric germ cell tumors.

Authors:  James F Amatruda; Julie A Ross; Brock Christensen; Nicholas J Fustino; Kenneth S Chen; Anthony J Hooten; Heather Nelson; Jacquelyn K Kuriger; Dinesh Rakheja; A Lindsay Frazier; Jenny N Poynter
Journal:  BMC Cancer       Date:  2013-06-27       Impact factor: 4.430

5.  Novel retrotransposed imprinted locus identified at human 6p25.

Authors:  Aiping Zhang; David A Skaar; Yue Li; Dale Huang; Thomas M Price; Susan K Murphy; Randy L Jirtle
Journal:  Nucleic Acids Res       Date:  2011-03-18       Impact factor: 16.971

6.  Genome wide DNA methylation profiles provide clues to the origin and pathogenesis of germ cell tumors.

Authors:  Martin A Rijlaarsdam; David M J Tax; Ad J M Gillis; Lambert C J Dorssers; Devin C Koestler; Jeroen de Ridder; Leendert H J Looijenga
Journal:  PLoS One       Date:  2015-04-10       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.